Inspire Medical Systems, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Inspire Medical Systems, Inc. (INSP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $13.74 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-13
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $571.00K, a 92.35% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $1.03M, a 94.12% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-06-30 was $4.34M, a 58.42% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-03-31 was $7.79M, a 43.13% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $13.74M, a 72.09% decline from fiscal 2024.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $49.22M, a 53.54% decline from fiscal 2023.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $105.95M, a 45.07% increase from fiscal 2022.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $73.04M, a 25.15% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2025-12-31 | $571.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.61M derived: sum of 2 quarters · filed 2026-02-13 | $5.94M derived: sum of 3 quarters · filed 2026-02-13 | $13.74M 10-K · filed 2026-02-13 |
| 2025-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $5.37M derived: sum of 2 quarters · filed 2025-11-03 | $13.17M 10-Q · filed 2025-11-03 | $20.63M derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | $4.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $12.13M 10-Q · filed 2025-08-04 | $19.60M derived: sum of 3 quarters · filed 2026-02-13 | $37.22M derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | $7.79M 10-Q · filed 2025-05-05 | $15.26M derived: sum of 2 quarters · filed 2026-02-13 | $32.88M derived: sum of 3 quarters · filed 2026-02-13 | $43.31M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | $7.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $25.08M derived: sum of 2 quarters · filed 2026-02-13 | $35.51M derived: sum of 3 quarters · filed 2026-02-13 | $49.22M 10-K · filed 2026-02-13 |
| 2024-09-30 | $17.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $28.05M derived: sum of 2 quarters · filed 2024-11-04 | $41.76M 10-Q · filed 2024-11-04 | $74.81M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $10.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $24.14M 10-Q · filed 2024-08-06 | $57.20M derived: sum of 3 quarters · filed 2026-02-13 | $71.35M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $13.71M 10-Q · filed 2024-05-07 | $46.76M derived: sum of 2 quarters · filed 2026-02-13 | $60.92M derived: sum of 3 quarters · filed 2026-02-13 | $90.23M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $33.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $47.21M derived: sum of 2 quarters · filed 2026-02-13 | $76.52M derived: sum of 3 quarters · filed 2026-02-13 | $105.95M 10-K · filed 2026-02-13 |
| 2023-09-30 | $14.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $43.46M derived: sum of 2 quarters · filed 2023-11-07 | $72.90M 10-Q · filed 2023-11-07 | $101.02M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $29.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $58.74M 10-Q · filed 2023-08-01 | $86.86M derived: sum of 3 quarters · filed 2025-02-10 | |
| 2023-03-31 | $29.43M 10-Q · filed 2023-05-02 | $57.55M derived: sum of 2 quarters · filed 2025-02-10 | ||
| 2022-12-31 | $28.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $73.04M 10-K · filed 2025-02-10 | ||
| 2022-09-30 | $44.92M 10-Q · filed 2022-11-01 | |||
| 2021-12-31 | $58.36M 10-K · filed 2024-02-09 | |||
| 2020-12-31 | $54.82M 10-K · filed 2023-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |